Legal Document View

Unlock Advanced Research with PRISMAI

Integrated with over 4 crore judgments and laws — designed for legal practitioners, researchers, students and institutions

- Know your Kanoon - Doc Gen Hub - Counter Argument - Case Predict AI - Talk with IK Doc - ...
Upgrade to Premium
[Cites 0, Cited by 0] [Entire Act]

Union of India - Section

Section 32 in Drugs (Prices Control) Order, 2013

32. Non-application of the provisions of this order in certain cases.

- The provisions of this order shall not apply to, -(i)a manufacturer producing a new drug patented under the Indian Patent Act, 1970 (39 of 1970) (product patent) and not produced elsewhere, if developed through indigenous Research and Development, for a period of five years from the date of commencement of its commercial production in the country.(ii)a manufacturer producing a new drug in the country by a new process developed through indigenous Research and Development and patented under the Indian Patent Act, 1970 (39 of 1970) (process patent) for a period of five years from the date of the commencement of its commercial production in the country.(iii)a manufacturer producing a new drug involving a new delivery system developed through indigenous Research and Development for a period of five years from the date of its market approval in India:Provided that the provision of this paragraph shall apply only when a document showing approval of such new drugs from Drugs Controller General (India) is produced before the Government.Explanation. - Notwithstanding anything contained in this Order, for the purpose of this paragraph "new drug" shall have the same meaning as is assigned to under rule 122E of the Drugs and Cosmetics Rules, 1945;[Schedule-INational List of Essential Medicines 2015[See paragraphs-2(t), 2(zb)]
(Symbols P, S and T appearing in this Scheduledenote essentiality at Primary, Secondary and Tertiary levelsrespectively)
Section 1-Anesthetic agents
1.1-General Anesthetics and oxygen
  Medicine Level of Healthcare Dosage form and strength
1.1.1 Halothane S,T Inhalation
1.1.2 Isoflurane S,T Inhalation
1.1.3 Ketamine P,S,T Injection 10 mg/mlInjection 50 mg/ml
1.1.4 Nitrous oxide P,S,T Inhalation
1.1.5 Oxygen P,S,T Inhalation (Medicinal gas)
1.1.6 Propofol P,S,T Injection 10 mg/ml
1.1.7 Sevoflurane T Inhalation
1.1.8 Thiopentone P,S,T Powder for Injection 0.5 gPowder for Injection 1 g
1.2-Local anesthetics
  Medicine Level of Healthcare Dosage form and strength
1.2.1 Bupivacaine S,T Injection 0.25%Injection 0.5%Injection 0.5% with 7.5% glucose
1.2.2 Lignocaine P,S,T Topical forms 2-5%Injection 1%Injection 2%Injection 5% with 7.5% Glucose
1.2.3 Lignocaine (A) + P,S,T Injection 1% (A) + 1 :200000 (5 mcg/ml) (B)
  Adrenaline (B)    
      Injection 2% (A) + 1 :200000 (5
1.2.4 Prilocaine (A) + T Cream 2.5% (A) + 2.5% (B)
  Lignocaine (B)    
1.3-Preoperative medication and sedation for short termprocedures
  Medicine Level of Healthcare Dosage form and strength
1.3.1 Atropine P,S,T Injection 0.6 mg/ml
1.3.2 Glycopyrrolate S,T Injection 0.2 mg/ml
1.3.3 Midazolam P,S,T Tablet 7.5 mgTablet 15 mgOral liquid 2 mg/mlInjection 1 mg/mlInjection 5 mg/ml
1.3.4 Morphine P,S,T Injection 10 mg/mlInjection 15 mg/ml
Section 2- Analgesics, antipyretics, non steroidal antiinflammatory medicines, medicines used to treat gout and diseasemodifying agents used in rheumatoid disorders
2.1- Non-opioid analgesics, antipyretics and no steroidal anti-inflammatory medicines
  Medicine Level of Healthcare Dosage form and strength
2.1.1 Acetylsalicylicacid P,S,T Tablet 300 mg to 500 mg
      Effervescent/ Dispersible/ Enteric coated Tablet 300 mg to 500mg
2.1.2 Diclofenac P,S,T Tablet 50 mgInjection 25 mg/ml
2.1.3 Ibuprofen P,S,T Tablet 200 mgTablet 400 mgOral liquid 100 mg/5 ml
2.1.4 Mefenamic acid P,S,T Capsule 250 mgCapsule 500 mgOral liquid 100 mg/5 ml
2.1.5 Paracetamol P,S,T Tablet 500 mgTablet 650 mgAll licenced oral liquid dosage forms and strengthsInjection 150 mg/mlSuppository 80 mgSuppository 170 mg
2.2-Opioid analgesics
  Medicine Level of Healthcare Dosage form and strength
2.2.1 Fentanyl S,T Injection 50 mcg/ml
2.2.2 Morphine P,S,T Tablet 10 mgInjection 10 mg/mlInjection 15 mg/ml
2.2.3 Tramadol S,T Capsule 50 mgCapsule 100 mgInjection 50 mg/ml
2.3-Medicines used to treat gout
  Medicine Level of Healthcare Dosage form and strength
2.3.1 Allopurinol P,S,T Tablet 100 mgTablet 300 mg
2.3.2 Colchicine P,S,T Tablet 0.5 mg
2.4-Disease modifying agents used in rheumatoid disorders
  Medicine Level of Healthcare Dosage form and strength
2.4.1 Azathioprine S,T Tablet 50 mg
2.4.2 Hydroxychloroquine S,T Tablet 200 mg
      Tablet 400 mg
2.4.3 Leflunomide S,T Tablet 10 mgTablet 20 mg
2.4.4 Methotrexate S,T Tablet 5 mgTablet 7.5 mgTablet 10 mgInjection 25 mg/ ml
2.4.5 Sulfasalazine S,T Tablet 500 mg
Section 3-Antiallergics and medicines used in anaphylaxis
  Medicine Level of Healthcare Dosage form and strength
3.1 Adrenaline P,S,T Injection 1 mg/ml
3.2 Cetirizine P,S,T Tablet 10 mgOral liquid 5 mg/5ml
3.3 Chlorpheniramine P,S,T Tablet 4 mgOral liquid 2 mg/5 ml
3.4 Dexamethasone P,S,T Tablet 0.5 mg
3.5 Hydrocortisone P,S,T Powder for Injection 100 mg
3.6 Pheniramine P,S,T Injection 22.75 mg/ml
3.7 Prednisolone P,S,T Tablet 5 mgTablet 10 mgTablet 20 mgOral liquid 5 mg/5 mlOral liquid 15 mg/5 ml
Section 4-Antidotes and other substances used in poisoning
4.1- Nonspecific      
  Medicine Level of Healthcare Dosage form and strength
4.1.1 Activated charcoal P,S,T Powder (as licensed)
4.2-Specific
  Medicine Level of Healthcare Dosage form and strength
4.2.1 Atropine P,S,T Injection 1 mg/ml
4.2.2 Calcium gluconate P,S,T Injection 100 mg/ml
4.2.3 Desferrioxamine S,T Powder for Injection 500 mg
4.2.4 Dimercaprol S,T Injection 50 mg/ml
4.2.5 Methylthioninium chloride (Methylene blue) S,T Injection 10 mg/ml
4.2.6 N-acetylcysteine P,S,T Sachet 200 mg
      Injection 200 mg/ml
4.2.7 Naloxone P,S,T m Injection 0.4 mg/ml
4.2.8 Neostigmine P,S,T Injection 0.5 mg/ml
4.2.9 Penicillamine S,T Capsule 250 mg
4.2.10 Pralidoxime chloride (2- PAM) P,S,T Injection 25 mg/ml
4.2.11 Snake venom antiseruma) Soluble/ liquid polyvalent P,S,T a) Injectionb) Powder for Injection
4.2.12 Sodium nitrite S,T Injection 30 mg/ml
4.2.13 Sodium S,T Injection 100 mg/ml
Section 5-Anticonvulsants/Antiepileptics
  Medicine Level of Healthcare Dosage form and strength
5.1 Carbamazepine P,S,T Tablet 100 mgTablet 200 mgCR Tablet 200 mgTablet 400 mgCR Tablet 400 mgOral liquid 100 mg/5 mlOral liquid 200 mg/5 ml
5.2 Clobazam S,T Tablet 5 mgTablet 10 mg
5.3 Diazepam P,S,T Oral liquid 2 mg/5 mlInjection 5 mg/mlSuppository 5 mg
5.4 Levetiracetam S,T Tablet 250 mgTablet 500 mgTablet 750 mgER Tablet 750 mgOral liquid 100 mg/mlInjection 100 mg/ml
5.5 Lorazepam P,S,T Tablet 1 mgTablet 2 mgInjection 2 mg/ml
5.6 Magnesium sulphate S,T Injection 500 mg/ml
5.7 Phenobarbitone P,S,TS,T Tablet 30 mgTablet 60 mgOral liquid 20 mg/5 mlInjection 200 mg/ml
5.8 Phenytoin P,S,T Tablet 50 mgTablet 100 mgTablet 300 mgER Tablet 300 mgOral liquid 30 mg/5 mlOral liquid 125 mg/5 mlInjection 25 mg/mlInjection 50 mg/ml
5.9 Sodium valproate P,S,T Tablet 200 mgTablet 300 mgCR Tablet 300 mgTablet 500 mgCR Tablet 500 mgOral liquid 200 mg/5ml
T Injection 100 mg/ml
Section 6-Anti infective medicines
6.1-Anthelminthics
6.1.1-Intestinal anthelminthics
  Medicine Level of Healthcare Dosage form and strength
6.1.1.1 Albendazole P,S,T Tablet 400 mgOral liquid 200 mg/5 ml
6.1.1.2 Mebendazole P,S,T Tablet 100 mgOral liquid 100 mg/5 ml
6.1.2- Antifilarial
  Medicine Level of Healthcare Dosage form and strength
6.1.2.1 Diethy lcarbamazine P,S,T Tablet 50 mgTablet 100 mgOral liquid 120 mg/5 ml
6.1.3-Anti-schistosomal & anti-trematodal medicine
  Medicine Level of Healthcare Dosage form and strength
6.1.3.1 Praziquantel S,T Tablet 600 mg
6.2-Antibacterials
6.2.1-Beta lactam medicines
  Medicine Level of Healthcare Dosage form and strength
6.2.1.1 Amoxicillin P,S,T Capsule 250 mgCapsule 500 mgOral liquid 250 mg/5 ml
6.2.1.2 Amoxicillin (A) + Clavulanic acid (B) P,S,T Tablet 500 mg (A) + 125 mg (B)Oral liquid 200 mg (A) + 28.5 mg (B)/5 mlDry Syrup 125 mg (A) + 31.25 (B)/5 ml
    S,T Powder for Injection 500 mg (A) + 100 mg (B)Powder for Injection 1 g (A) + 200 mg (B)
6.2.1.3 Ampicillin P,S,T Powder for Injection 500 mgPowder for Injection 1 g
6.2.1.4 Benzathine benzylpenicillin P,S,T Powder for Injection 6 lac unitsPowder for Injection 12 lac units
6.2.1.5 Benzyl penicillin P,S,T Powder for Injection 10 lac units
6.2.1.6 Cefadroxil P,S,T Tablet 500 mgTablet 1 gOral liquid 125 mg/5 ml
6.2.1.7 Cefazolin P,S,T Powder for Injection 500 mgPowder for Injection 1 g
6.2.1.8 Cefixime S,T Tablet 200 mgTablet 400 mgOral liquid 50 mg/5 mlOral liquid 100 mg/5 ml
6.2.1.9 Cefotaxime S,T Powder for Injection 250 mgPowder for Injection 500 mgPowder for Injection 1 g
6.2.1.10 Ceftazidime S,T Powder for Injection 250 mgPowder for Injection 1 g
6.2.1.11 Ceftriaxone S,T Powder for Injection 250 mgPowder for Injection 500 mgPowder for Injection 1 gPowder for Injection 2 g
6.2.1.12 Cloxacillin P,S,T Capsule 250 mgCapsule 500 mgOral Liquid 125 mg/5 mlPowder for Injection 250 mg
6.2.1.13 Piperacillin (A) + Tazobactam (B) T Powder for Injection 1 g (A) + 125 mg (B)Powder for Injection 2 g (A) + 250 mg (B)Powder for Injection 4 g (A) + 500 mg (B)
6.2.2-Other antibacterials
  Medicine Level of Healthcare Dosage form and strength
6.2.2.1 Azithromycin P,S,T Tablet 250mgTablet 500mgOral liquid 200 mg/5 mlPowder for Injection 500mg
6.2.2.2 Ciprofioxacin P,S,T Tablet 250mgTablet 500mgOral liquid 250mg/5mlInjection 200 mg/100ml
6.2.2.3 Clarithromycin S,T Tablet 250mgTablet 500mgOral liquid 125mg/5ml
6.2.2.4 Co-trimoxazole [Sulphamethoxazol e (A) + Trimethoprim (B)] P,S,T Tablet 400 mg (A) + 80 mg (B)Tablet 800 mg (A) + 160 mg (B)Oral liquid 200 mg (A) + 40 mg (B)/5 ml
6.2.2.5 Doxycycline P,S,T Capsule 100 mgDry Syrup 50 mg/5 ml
6.2.2.6 Gentamicin P,S,T Injection 10 mg/mlInjection 40 mg/ml
6.2.2.7 Metronidazole P,S,T Tablet 200 mgTablet 400 mgOral liquid 200 mg/5 mlInjection 500mg/100 ml
6.2.2.8 Nitrofurantoin P,S,T Tablet 100 mgOral liquid 25 mg/5 ml
6.2.2.9 Vancomycin T Powder for Injection 250 mgPowder for Injection 500 mgPowder for Injection 1 g
6.2.3-Antileprosy medicines
  Medicine Level of Healthcare Dosage form and strength
6.2.3.1 Clofazimine P,S,T Capsule 50 mg Capsule 100 mg
6.2.3.2 Dapsone P,S,T Tablet 25 mgTablet 50 mgTablet 100 mg
6.2.3.3 Rifampicin P,S,T Capsule 150 mgCapsule 300 mg
6.2.4-Antituberculosis medicines
  Medicine Level of Healthcare Dosage form and strength
6.2.4.1 Capreomycin P,S,T Powder for Injection 1 g
6.2.4.2 Cycloserine P,S,T Capsule 125 mgCapsule 250 mg
6.2.4.3 Ethambutol P,S,T Tablet 200 mgTablet 400 mgTablet 600 mgTablet 800 mg
6.2.4.4 Ethionamide P,S,T Tablet 125 mgTablet 250 mg
6.2.4.5 Isoniazid P,S,T Tablet 50 mgTablet 100 mgTablet 300 mgOral liquid 100 mg/5 ml
6.2.4.6 Kanamycin P,S,T Powder for Injection 500 mgPowder for Injection 750 mgPowder for Injection 1 g
6.2.4.7 Levofloxacin P,S,T Tablet 250 mgTablet 500 mgTablet 750 mg
6.2.4.8 Linezolid P,S,T Tablet 600 mg
6.2.4.9 Moxifloxacin P,S,T Tablet 200 mgTablet 400 mg
6.2.4.10 Paraamino salicylic acid P,S,T Tablet 500 mg Granules (As licensed)
6.2.4.11 Pyrazinamide P,S,T Tablet 500 mgTablet 750 mgTablet 1000 mgTablet 1500 mgOral liquid 250 mg/5 ml
6.2.4.12 Rifabutin S,T Capsule 150 mg
6.2.4.13 Rifampicin P,S,T Capsule 150 mgCapsule 300 mgCapsule 450 mgCapsule 600 mgOral liquid 100 mg/5 ml
6.2.4.14 Streptomycin P,S,T Powder for Injection 750 mgPowder for Injection 1 g
6.3-Antifungal medicines
  Medicine Level of Healthcare Dosage form and strength
6.3.1 Amphotericin B a) Amphotericin B (conventional) b) LipidLiposomal Amphotericin B S,T Powder for Injection 50 mg
6.3.2 Clotrimazole P,S,T Pessary 100 mg
6.3.3 Fluconazole P,S,T Tablet 100 mgTablet 150 mgTablet 200mgTablet 400 mgOral liquid 50 mg/5 ml
S,T Injection 200 mg /100 ml
6.3.4 Griseofulvin P,S,T Tablet 125 mgTablet 250 mgTablet 375 mg
6.3.5 Nystatin P,S,T Tablet 500,000 IUPessary 100,000 IUOral Liquid 100, 000 IU/ml
6.4-Antiviral medicines
6.4.1-Antiherpes medicines      
  Medicine Level of Healthcare Dosage form and strength
6.4.1.1 Acyclovir P,S,T Tablet 200 mgTablet 400 mgPowder for Injection 250 mgPowder for Injection 500 mgOral liquid 400 mg/5 ml
6.4.2-Anti Cytomegalovirus (CMV) medicines
6.4.2.1 Ganciclovir S,T Capsule 250 mgPowder for Injection 500 mg
6.4.3-Antiretroviral medicines
6.4.3.1-Nucleoside reverse transcriptase inhibitors
  Medicine Level of Healthcare Dosage form and strength
6.4.3.1.1 Abacavir S,T Tablet 60 mgTablet 300 mg
6.4.3.1.2 Abacavir (A) + Lamivudine (B) S,T Tablet 60 mg (A) +30 mg (B)Tablet 600 mg (A)+ 300 mg (B)
6.4.3.1.3 Lamivudine (A) + Nevirapine (B) + Stavudine (C) S,T Dispersible Tablet 30 mg (A) + 50 mg (B) + 6 mg (C)Tablet 150 mg (A) + 200 mg (B) + 30 mg (C)
6.4.3.1.4 Lamivudine (A) + Zidovudine (B) S,T Tablet 30 mg (A) + 60 mg (B)Tablet 150 mg (A) + 300 mg (B)
6.4.3.1.5 Stavudine (A) + Lamivudine (B) S,T Dispersible Tablet 6 mg (A) + 30 mg (B)Tablet 30 mg (A) + 150 mg (B)
6.4.3.1.6 Tenofovir (A) + Lamivudine (B) S,T Tablet 300 mg (A) +300 mg (B)
6.4.3.1.7 Tenofovir (A) + Lamivudine (B) + Efavirenz (C) S,T Tablet 300 mg (A) + 300 mg (B) + 600 mg (C)
6.4.3.1.8 Zidovudine S,T Tablet 300 mgOral liquid 50 mg/5 ml
6.4.3.1.9 Zidovudine (A) + Lamivudine (B) + Nevirapine (C) S,T Tablet 60 mg (A) + 30 mg (B) + 50 mg (C)Tablet 300 mg (A) + 150 mg (B) + 200 mg (C)
6.4.3.2-Non-nucleoside reverse transcriptase inhibitors
  Medicine Level of Healthcare Dosage form and strength
6.4.3.2.1 Efavirenz S,T Tablet 50 mgTablet 200 mgTablet 600 mg
6.4.3.2.2 Nevirapine S,T Dispersible Tablet 50 mgTablet 200 mgOral liquid 50 mg/5 ml
6.4.3.3-Integrase inhibitors
6.4.3.3.1 Raltegravir S,T Tablet 400 mg
6.4.3.4-Protease inhibitors
  Medicine Level of Healthcare Dosage form and strength
6.4.3.4.1 Atazanavir (A) + Ritonavir (B) S,T Tablet 300 mg (A) + 100 mg (B)
6.4.3.4.2 Darunavir S,T Tablet 600 mg
6.4.3.4.3 Lopinavir (A) + Ritonavi (B) S,T Tablet 100mg (A) + 25 mg (B)Tablet 200mg (A) + 50 mg (B)Oral liquid 400mg (A)mg (B)/5ml
6.4.3.4.4 Ritonavir S,T Tablet 100 mg
6.4.4-Medicines for hepatitis B and hepatitis C
6.4.4.1 Entecavir S,T Tablet 0.5 mg Tablet 1 mg
6.4.4.2 Pegylated interferon alfa 2a S,T Injection 180 mcg
S,T Injection 80 mcgInjection 100 mcgInjection 120 mcg
6.4.4.3 Ribavirin S,T Capsule 200 mg
6.4.4.4 Sofosbuvir S,T Tablet 400 mg
6.4.4.5 Tenofovir S,T Tablet 300 mg
Section 6.5-Antiprotozoal Medicines
6.5.1-Antiamoebic and antigiardiasis medicines
  Medicine Level of Healthcare Dosage form and strength
6.5.1.1 Diloxanide furoate P,S,T Tablet 500 mg
6.5.1.2 Metronidazole P,S,T Tablet 200 mgTablet 400 mgInjection 500 mg/100 mlOral liquid 200 mg/5 ml
6.5.2-Antileishmaniasis medicines
  Medicine Level of Healthcare Dosage form and strength
6.5.2.1 Amphotericin B a) Amphotericin B (conventional) b) LipidLiposomal Amphotericin B S,T Powder for Injection 50 mg
6.5.2.2 Miltefosine P,S,T Capsule 10 mgCapsule 50 mg
6.5.2.3 Paromomycin P,S,T Injection 375 mg/ml
6.S.3-Antimalarial medicines
6.S.3.1-For curative treatment
  Medicine Level of Healthcare Dosage form and strength
6.5.3.1.1 Artemether (A) + Lumefantrine (B) P,S,T Tablet 20 mg (A) + 120 mg (B)Tablet 40 mg (A) + 240 mg (B)Tablet 80 mg (A) + 480 mg (B)Oral liquid 80 mg (A) + 480 mg (B)/5 ml
6.5.3.1.2 Artesunate P,S,T Powder for Injection 60 mgPowder for Injection 120 mg
6.5.3.1.3 Artesunate (A) + Sulphadoxine - Pyrimethamine (B) P,S,T Combi pack (A+B) 1 Tablet 25 mg (A) +1 Tablet (250 mg + 12.5 mg) (B)1 Tablet 50 mg (A) +1 Tablet (500 mg + 25 mg) (B)1 Tablet 100 mg (A) + 1 Tablet (750 mg + 37.5 mg) (B)1 Tablet 150 mg (A) + 2 Tablet (500 mg + 25 mg) (B)1 Tablet 200 mg (A) + 2 Tablet (750 mg + 37.5 mg) (B)
6.5.3.1.4 Chloroquine P,S,T Tablet 150 mgOral liquid 50 mg/5 ml
6.5.3.1.5 Clindamycin P,S,T Capsule 150 mgCapsule 300 mg
6.5.3.1.6 Primaquine P,S,T Tablet 2.5 mgTablet 7.5 mgTablet 15 mg
6.5.3.1.7 Quinine P,S,T Tablet 300 mg Injection 300 mg/ml
6.5.3.2-For prophylaxis
  Medicine Level of Healthcare Dosage form and strength
6.5.3.2.1 Mefloquine T Tablet 250 mg*Only for use as chemoprophylaxis for long term travellerslike military and travel troops, travelling from low endemic tohigh endemic area.
6.5.4-Antipneumocystosis and anti toxoplasmosis medicines
  Medicine Level of Healthcare Dosage form and strength
6.5.4.1 Co-trimoxazole [Sulphamethoxazol e (A) + Trimethoprim (B)] P,S,T Tablet 400 mg (A) + 80 mg (B)Tablet 800 mg (A) + 160 mg (B)Oral liquid 200 mg (A) + 40 mg (B)/5 ml
6.5.4.2 Pentamidine S,T Powder for Injection 200 mg
Section 7 -Antimigraine medicines
Medicine Level of Healthcare Dosage form and strength      
7.1.1 Acetylsalicylic acid P,S,T Tablet 300 mg to 500 mgEffervescent/ Dispersible/ Enteric coated Tablet 300 mg to 500mg
7.1.2 Paracetamol P,S,T Tablet 500 mgTablet 650 mg
7.1.3 Sumatriptan P,S,T Injection 6 mg/ 0.5 mlTablet 25 mgTablet 50 mg
7.2-For prophylaxis
  Medicine Level of Healthcare Dosage form and strength
7.2.1 Flunarizine P,S,T Tablet 5 mgTablet 10 mg
7.2.2 Propranolol P,S,T Tablet 10 mgTablet 40 mgTablet 80 mg
Section 8 -Antineoplastic/immunosuppressives and medicinesused in palliative care
8.1-Antineoplastic medicines
  Medicine Level of Healthcare Dosage form and strength
8.1.1 5- Fluorouracil T Injection 250 mg/5 ml
8.1.2 6- Mercaptopurine T Tablet 50 mg
8.1.3 Actinomycin D T Powder for Injection 0.5 mg
8.1.4 All-trans retinoic acid T Capsule 10 mg
8.1.5 Arsenic trioxide T Injection 1mg/ml
8.1.6 Bleomycin T Powder for Injection 15 units
8.1.7 Bortezomib T Powder for Injection 2mg
8.1.8 Calcium folinate T Tablet 15 mgInjection 3 mg/ml
8.1.9 Capecitabine T Tablet 500 mg
8.1.10 Carboplatin T Injection 10 mg/ml
8.1.11 Chlorambucil T Tablet 2 mgTablet 5 mg
8.1.12 Cisplatin T Injection 1 mg/ml
8.1.13 Cyclophosphamide T Tablet 50 mgTablet 200 mgPowder for Injection 500 mg
8.1.14 Cytosine arabinoside T Injection 100 mg/ mlPowder for Injection 500 mgPowder for Injection 1000 mg
8.1.15 Dacarbazine T Powder for Injection 500 mg
Powder for Injection 200 mg      
8.1.16 Daunorubicin T Injection 5 mg/ml
8.1.17 Docetaxel T Powder for Injection 20 mgPowder for Injection 80 mg
8.1.18 Doxorubicin T Injection 2 mg/ml
8.1.19 Etoposide T Capsule 50 mgCapsule 100 mgInjection 20 mg/ml
8.1.20 Gefitinib T Tablet 250 mg
8.1.21 Gemcitabine T Powder for Injection 200 mgPowder for Injection 1 g
8.1.22 Ifosfamide T Powder for Injection 1 gPowder for Injection 2 g
8.1.23 Imatinib T Tablet 100 mgTablet 400 mg
8.1.24 L- Asparaginase T Powder for Injection 5000 KU.Powder for Injection 10000 KU
8.1.25 Melphalan T Tablet 2 mgTablet 5 mg
8.1.26 Mesna T Injection 100 mg/ml
8.1.27 Methotrexate T Tablet 2.5 mgTablet 5 mgTablet 10mgInjection 50 mg/ml
8.1.28 Oxaliplatin T Injection 5 mg/ml
8.1.29 Paclitaxel T Injection 30 mg/5 mlInjection 100 mg/16.7 ml
8.1.30 Procarbazine T Capsule 50 mg
8.1.31 Rituximab T Injection 10 mg/ml
8.1.32 Temozolomide T Capsule 20 mgCapsule 100 mgCapsule 250 mg
8.1.33 Thalidomide T Capsule 50 mgCapsule 100 mg
8.1.34 Trastuzumab T Injection 440 mg/50 ml
8.1.35 Vinblastine T Injection 1 mg/ml
8.1.36 Vincristine T Injection 1 mg/ml
8.2-Hormones and antihormones used in cancer therapy
  Medicine Level of Healthcare Dosage form and strength
8.2.1 Bicalutamide T Tablet 50 mg
8.2.2 Letrozole T Tablet 2.5 mg
8.2.3 Prednisolone S, T Tablet 10 mgTablet 20 mgTablet 40 mgOral liquid 5 mg/5 mlOral liquid 15 mg/5 mlInjection 20 mg/2 ml
8.2.4 Tamoxifen T Tablet 10 mgTablet 20 mg
8.3-Immunosuppressive medicines
  Medicine Level of Healthcare Dosage form and strength
8.3.1 Azathioprine T Tablet 50 mg
8.3.2 Cyclosporine T Capsule 10 mgCapsule 25 mgCapsule 50 mgCapsule 100 mgOral liquid 100 mg/mlInjection 50 mg/ml
8.3.3 M ycophenolate mofetil T Tablet 250 mgTablet 500 mg
8.3.4 Tacrolimus T Capsule 0.5 mgCapsule 1 mgCapsule 2 mg
S.4-Medicines used in palliative care
  Medicine Level of Healthcare Dosage form and strength
8.4.1 Allopurinol T Tablet 100 mg
8.4.2 Amitriptyline T Tablet 10 mgTablet 25 mg
8.4.3 Dexamethasone T Tablet 0.5 mgInjection 4 mg/ml
8.4.4 Diazepam T Tablet 2 mgTablet 5 mgInjection 5 mg/ml
8.4.5 Filgrastim T Injection 300 mcg
8.4.6 Fluoxetine T Capsule 20 mg
8.4.7 Haloperidol T Tablet 1.5 mgTablet 5 mgInjection 5 mg/ml
8.4.8 Lactulose T Oral liquid 10 g/15 ml
8.4.9 Loperamide T Tablet 2 mg
8.4.10 Metoclopramide T Tablet 10 mgOral liquid 5 mg/5 mlInjection 5 mg/ml
8.4.11 Midazolam T Injection 1 mg/ml
8.4.12 Morphine T   Tablet 10 mgTablet 20 mgSR Tablet 30 mg
8.4.13 Ondansetron S,T Tablet 4 mgTablet 8 mgOral liquid 2 mg/5 mlInjection 2 mg/ml
8.4.14 Tramadol T Capsule 50 mgCapsule 100 mgInjection 50 mg/ml
8.4.15 Zoledronic acid T Powder for Injection 4 mg
Section 9-Antiparkinsonism medicines
  Medicine Level of Healthcare Dosage form and strength
9.1 Levodopa (A) + Carbidopa (B) P,S,T Tablet 100 mg (A) + 10 mg (B)Tablet 100 mg (A) + 25 mg (B)CR Tablet 100 mg (A) + 25 mg (B)CR Tablet 200 mg (A) + 50 (B) mgTablet 250 mg (A) + 25 mg (B)
9.2 Trihexyphenidyl P,S,T Tablet 2 mg
Section 10- Medicines affecting blood
10.1- Antianaemia medicines
  Medicine Level of Healthcare Dosage form and strength
10.1.1 Erythropoietin S,T Injection 2000 IU/mlInjection 10000 IU/ml
10.1.2 Ferrous salts P,S,T Tablet equivalent to 60 mg of elemental ironOral liquid equivalent to 25 mg of elemental iron/ml
10.1.3 Ferrous salt (A) + Folic acid (B) P,S,T Tablet 45mg elemental iron (A) + 400 mcg (B)Tablet 100 mg elemental iron (A) + 500 mcg (B)Oralliqiud 20 mg elemental iron (A) + 100 mcg (B)/ml
10.1.4 Folic acid P,S,T Tablet 5 mg
10.1.5 Hydroxocobalamin P,S,T Injection 1 mg/ml
10.1.6 Hydroxyurea P,S,T Capsule 500 mg
10.1.7 Iron sucrose S,T Injection 20 mg/ml
10.2-Medicines affecting coagulation
  Medicine Level of Healthcare Dosage form and strength
10.2.1 Enoxaparin T Injection 40 mg/0.4 mlInjection 60 mg/0.6 ml
10.2.2 Heparin S,T Injection 1000 IU/mlInjection 5000 IU/ml
10.2.3 Phytomenadione (Vitamin K1) P,S,T Tablet 10mgInjection 10 mg/ml
10.2.4 Protamine S,T Injection 10 mg/ml
10.2.5 Tranexamic acid P,S,T Tablet 500 mgInjection 100 mg/ml
10.2.6 Warfarin S,T Tablet 1 mgTablet 2 mgTablet 3 mgTablet 5 mg
Section 11- Blood products and Plasma substitutes
11.1-Blood and Blood components
All forms of the following as approved by licensing authorityare considered as included in this schedule.However, considering the process, technology and otherrelevant aspects, they should be considered differently forpurposes such as procurement policy, pricing etc.
11.1.1 Fresh frozen plasma S,T As licensed
11.1.2 Platelet rich plasma S,T As licensed
11.1.3 Red blood cells S,T As licensed
11.1.4 Whole blood S,T As licensed
11.2-Plasma substitutes
  Medicine Level of Healthcare Dosage form and strength
11.2.1 Dextran-40 S,T Injection 10%
11.3-Plasma fractions for specific use
In case of coagulation factors and other blood products,irrespective of variation in source, all forms of these productsas approved by licensing authority are considered as included inas included in this schedule. However, considering the source,process, technology and other relevant aspects, and otherrelevant aspects, they should be considered differently forpurposes such as procurement policy, Procurement policy, pricingetc
  Medicine Level of Healthcare Dosage form and strength
11.3.1 Coagulation factor IX S,T Powder for Injection 600 IU
11.3.2 Coagulation factor VIII S,T Powder for Injection 250 IUPowder for Injection 500 IU
11.3.3 Cryoprecipitate S,T As licensed
Section 12-Cardiovascular medicines
12.1-Medicines used in angina
  Medicine Level of Healthcare Dosage form and strength
12.1.1 Acetylsalicylic acid P,S,T Tablet 75 mg Effervescent/ Dispersible/ Enteric coated Tablet75 mgTablet 100 mgEffervescent/ Dispersible/ Enteric coated Tablet 100 mgTablet 150 mgEffervescent/ Dispersible/ Enteric coated Tablet 150 mg
12.1.2 Clopidogrel P,S,T Tablet 75 mg
12.1.3 Diltiazem P,S,T Tablet 30 mgTablet 60 mgSR Tablet 90 mg
T Injection 5 mg/ml
12.1.4 Glyceryl trinitrate P,S,T Sublingual tablet 0.5 mg
S,T Injection 5 mg/ml
12.1.5 Isosorbide- 5- mononitrate P,S,T Tablet 10 mgTablet 20 mgSR Tablet 30 mgSR Tablet 60 mg
12.1.6 Isosorbide dinitrate P,S,T Tablet 5 mgTablet 10 mg
12.1.7 Metoprolol P,S,T Tablet 25 mgTablet 50 mgSR Tablet 25 mgSR Tablet 50 mg
12.2-Antiarrhythmic medicines
  Medicine Level of Healthcare Dosage form and strength
12.2.1 Adenosine S,T Injection 3 mg/ml
12.2.2 Amiodarone S,T Tablet 100 mgTablet 200 mgInjection 50 mg/ml
12.2.3 Esmolol T Injection 10 mg/ml
12.2.4 Lignocaine S,T Injection 2% (Preservative free for IV use)
12.2.5 Verapamil S,T Tablet 40 mgTablet 80 mgInjection 2.5 mg/ml
12.3-Antihypertensive medicines
  Medicine Level of Healthcare Dosage form and strength
12.3.1 Amlodipine P,S,T Tablet 2.5 mgTablet 5 mgTablet 10 mg
12.3.2 Atenolol P,S,T Tablet 50 mgTablet 100 mg
12.3.3 Enalapril P,S,T Tablet 2.5 mgTablet 5 mg
12.3.4 Hydrochlorothiazide P,S,T Tablet 12.5 mgTablet 25 mg
12.3.5 Labetalol P,S,T Injection 5 mg/ml
12.3.6 Methyldopa P,S,T Tablet 250 mgTablet 500 mg
12.3.7 Ramipril P,S,T Tablet 2.5 mgTablet 5 mg
12.3.8 Sodium nitroprusside T Injection 10 mg/ml
12.3.9 Telmisartan P,S,T Tablet 20 mgTablet 40 mgTablet 80 mg
12.4-Medicines used in shock and heart failure
  Medicine Level of Healthcare Dosage form and strength
12.4.1 Digoxin S,T Tablet 0.25 mgOral liquid 0.05 mg/mlInjection 0.25 mg/ml
12.4.2 Dobutamine S,T Injection 50 mg/ml
12.4.3 Dopamine S,T Injection 40 mg/ml
12.4.4 Noradrenaline S,T Injection 2 mg/ml
12.5-Antithrombotic medicine (Cardiovascular/ Cerebrovascular)
  Medicine Level of Healthcare Dosage form and strength
12.5.1 Acetylsalicylic acid P,S,T Tablet 75 mgEffervescent/ Dispersible/ Enteric coated Tablet 75 mgTablet 100 mgEffervescent/ Dispersible/ Enteric coated Tablet 100 mgTablet 150 mgEffervescent/ Dispersible/ Enteric coated Tablet 150 mg
12.5.2 Alteplase T Powder for Injection 20 mgPowder for Injection 50 mg
12.5.3 Heparin S,T Injection 1000 IU/mlInjection 5000 IU/ml
12.5.4 Streptokinase S,T Injection 750,000 IU Injection 15,00,000 IU
12.6-Hypolipidemic medicines
  Medicine Level of Healthcare Dosage form and strength
12.6.1 Atorvastatin P,S,T Tablet 10 mgTablet 20 mgTablet 40 mg
Section 13-Medicines used in dementia
  Medicine Level of Healthcare Dosage form and strength
13.1 Donepezil S,T Tablet 5 mgTablet 10 mg
Section 14- Dermatological medicines (Topical)
14.1- Antifungal medicines
  Medicine Level of Healthcare Dosage form and strength
14.1.1 Clotrimazole P,S,T Cream 1%
14.2- Antiinfective medicines
  Medicine Level of Healthcare Dosage form and strength
14.2.1 Framycetin P,S,T Cream 0.5%
14.2.2 Fusidic acid P,S,T Cream 2%
14.2.3 Methylrosanilinium chloride (Gentian Violet) P,S,T Topial preparation 0.25% to 2%
14.2.4 Povidone iodine P,S,T Solution 4% to 10%
14.2.5 Silver sulphadiazine P,S,T Cream 1%
14.3-Antiinflammatory and antipruritic medicines
  Medicine Level of Healthcare Dosage form and strength
14.3.1 Betamethasone P,S,T Cream 0.05%Cream 0.1%
14.3.2 Calamine P,S,T Lotion (As per IP)
14.4-Medicines affecting skin differentiation andproliferation
  Medicine Level of Healthcare Dosage form and strength
14.4.1 Benzoyl peroxide P,S,T Gel 2.5%
14.4.2 Coal tar P,S,T Solution 5%
14.4.3 Podophyllin resin S,T Solution 10% to 25%
14.4.4 Salicylic acid P,S,T Ointment 6%
14.5-Scabicides and pediculicides
  Medicine Level of Healthcare Dosage form and strength
14.5.1 Permethrin P,S,T Lotion 1%Cream 5%
14.6-Miscellaneous
  Medicine Level of Healthcare Dosage form and strength
14.6.1 Glycerin P,S,T Oral Liquid
14.6.2 White Petrolatum P,S,T Jelly 100%
Section 15 - Diagnostic agents
15.1-Ophthalmic medicines
  Medicine Level of Healthcare Dosage form and strength
15.1.1 Fluorescein S,T Eye drop 1%
15.1.2 Lignocaine S,T Eye drop 4%
15.1.3 Tropicamide S,T Eye drop 1%
15.2-Radiocontrast media
  Medicine Level of Healthcare Dosage form and strength
15.2.1 Barium sulphate S,T Oral liquid 100% w/vOral liquid 250% w/v
15.2.2 Gadobenate T Injection 529 mg/ml
15.2.3 Iohexol S,T Injection 140 to 350 mg iodine/ml
15.2.4 Meglumine diatrizoate S,T Injection 60% w/vInjection 76% w/v
Section 16- Dialysis solutions
  Medicine Level of Healthcare Dosage form and strength
16.1 Haemodialysis fluid S,T As licensed
16.2 Intraperitoneal dialysis solution S,T As licensed
Section 17- Disinfectants and antiseptics
17.1-Antiseptics
  Medicine Level of Healthcare Dosage form and strength
17.1.1 Cetrimide P,S,T Solution 20% (Concentrate for dilution)
17.1.2 Chlorhexidine P,S,T Solution 5% (Concentrate for dilution)
17.1.3 Ethyl alcohol (Denatured) P,S,T Solution 70%
17.1.4 Hydrogen peroxide P,S,T Solution 6%
17.1.5 Methylrosaniliniu m chloride (Gentian Violet) P,S,T Topial preparation 0.25% to 2%
17.1.6 Povidone iodine P,S,T Solution 4% to 10%
17.2-Disinfectants
  Medicine Level of Healthcare Dosage form and strength
17.2.1 Bleaching powder P,S,T Containing not less than 30% w/w of available chlorine (as perIP)
17.2.2 Glutaraldehyde S,T Solution 2%
17.2.3 Potassium permanganate P,S,T Crystals for topical solution
Section 18- Diuretics
  Medicine Level of Healthcare Dosage form and strength
18.1 Furosemide P,S,T Tablet 40 mgOral liquid 10 mg/mlInjection 10 mg/ ml
18.2 Hydrochlorothiazide P,S,T Tablet 25 mgTablet 50 mg
18.3 Mannitol P,S,T Injection 10%Injection 20%
18.4 Spironolactone P,S,T Tablet 25 mgTablet 50 mg
Section 19- Ear, nose and throat medicines
19.1 Budesonide P,S,T Nasal Spray 50 mcg/doseNasal Spray 100 mcg/dose
19.2 Ciprofioxaein P,S,T Drops 0.3%
19.3 Clotrimazole P,S,T Drops 1%
19.4 Xylometazoline P,S,T Nasal drops 0.05%Nasal drops 0.1%
Section 20-Gastrointestinal medicines
20.1-Antiulcer medicines
  Medicine Level of Healthcare Dosage form and strength
20.1.1 Omeprazole P,S,T Capsule 10 mgCapsule 20 mgCapsule 40 mgPowder for oral liquid 20 mg
20.1.2 Pantoprazole S,T Injection 40 mg
20.1.3 Ranitidine P,S,T Tablet 150 mgOral liquid 75 mg/5 mlInjection 25 mg/ml
20.1.4 Sucralfate S,T Oral liquid 1 g
20.2-Antiemetics
  Medicine Level of Healthcare Dosage form and strength
20.2.1 Domperidone P,S,T Tablet 10 mgOral liquid 1 mg/ml
20.2.2 Metoclopramide P,S,T Injection 5 mg/ml
20.2.3 Ondansetron S,T Injection 2 mg/mlTablet 4 mgOral liquid 2 mg/5 ml
20.3- Anti- inflammatory medicines
  Medicine Level of Healthcare Dosage form and strength
20.3.1 5-aminosalicylic acid S,T Tablet 400 mgSuppository 500 mgRetention Enema
20.4-Antispasmodic medicines
  Medicine Level of Healthcare Dosage form and strength
20.4.1 Dicyclomine P,S,T Tablet 10 mgOral Solution 10mg/5mlInjection 10 mg/ml
20.4.2 Hyoscine butylbromide P,S,T Tablet 10 mg
      Injection 20 mg/ml
20.5-Laxatives
  Medicine Level of Healthcare Dosage form and strength
20.5.1 Bisacodyl P,S,T Tablet 5 mgSuppository 5 mg
20.5.2 Ispaghula P,S,T Granules/ Husk/ Powder
20.5.3 Lactulose S,T Oral liquid 10 g/15 ml
20.6-Medicines used in diarrhoea
  Medicine Level of Healthcare Dosage form and strength
20.6.1 Oral rehydration salts P,S,T As licensed
20.6.2 Zinc sulphate P,S,T Dispersible Tablet 20 mg
20.7-0ther medicines
20.7.1 Somatostatin T Powder for Injection 3 mg
Section 21-Hormones, other endocrine medicines andcontraceptives
21.1-Adrenal hormones and synthetic substitutes
  Medicine Level of Healthcare Dosage form and strength
21.1.1 Dexamethasone S,T Tablet 0.5 mgInjection 4 mg/ml
21.1.2 Human chorionic gonadotropin T Injection 1000 IUInjection 5000 IV
21.1.3 Hydrocortisone P,S,T Tablet 5 mgTablet 10 mgInjection 100 mg/ml
21.1.4 Methylprednisolone S,T Tablet 8 mgTablet 16 mgTablet 32 mgInjection 40 mg/ml
21.1.5 Prednisolone P,S,T Tablet 5 mgTablet 10 mgTablet 20 mg
21.2-Contraceptives
21.2.1-Hormonal contraceptives
  Medicine Level of Healthcare Dosage form and strength
21.2.1.1 Ethinylestradiol (A) + Levonorgestrel P,S,T Tablet 0.03 mg (A) + 0.15 mg (B)
21.2.1.2 Ethinylestradiol (A) + Norethisterone P,S,T Tablet 0.035 mg (A) + 1 mg (B)
21.2.2-Intrauterine devices
  Medicine Level of Healthcare Dosage form and strength
21.2.2.1 Hormone releasing IUD T Contains 52 mg of Levonorgestrel
21.2.2.2 IUD containing Copper P,S,T As licensed
21.2.3-Barrier methods
  Medicine Level of Healthcare Dosage form and strength
21.2.3.1 Condom P,S,T As per the standards prescribed in Schedule R of Drugs andCosmetics rules, 1945
21.3-Estrogens
  Medicine Level of Healthcare Dosage form and strength
21.3.1 Ethinylestradiol P,S,T Tablet 0.01 mgTablet 0.05 mg
21.3.2 Levonorgestrel P,S,T Tablet 0.75 mg
21.4- Medicines used in diabetes mellitus
21.4.1-Insulins and other antidiabetic agents
  Medicine Level of Healthcare Dosage form and strength
21.4.1.1 Glimepiride P,S,T Tablet 1 mgTablet 2 mg
21.4.1.2 Insulin (Soluble) P,S,T Injection 40 IU/ml
21.4.1.3 Intermediate Acting (NPH) Insulin P,S,T Injection 40 IU/ml
21.4.1.4 Metformin P,S,T Tablet 500 mgTablet 750 mgTablet 1000 mg(Immediate and controlled release)
21.4.1.5 Premix Insulin 30:70 Injection (Regular: NPH) P,S,T Injection 40 IU/ml
21.4.2-Medicines used to treat hypoglycemia
  Medicine Level of Healthcare Dosage form and strength
21.4.2.1 Glucose P,S,T Injection 25%
21.5-Ovulation Inducers
  Medicine Level of Healthcare Dosage form and strength
21.5.1 Clomiphene T Tablet 50 mgTablet 100 mg
21.6- Progestogens
  Medicine Level of Healthcare Dosage form and strength
21.6.1 Medroxyprogester oneacetate P,S,T Tablet 5 mg
      Tablet 10 mg
21.6.2 Norethisterone P,S,T Tablet 5 mg
21.7- Thyroid and antithyroid medicines
  Medicine Level of Healthcare Dosage form and strength
21.7.1 Carbimazole P,S,T Tablet 5 mg
      Tablet 10 mg
21.7.2 Levothyroxine P,S,T Tablet 12.5 mcg to 150 mcg* (Several strengths are availablein market such as 12.5, 25, 50, 62.5, 75, 88, 100, 112 mcg.Therefore it was Considered to give a range of availablestrengths)
Section 22- Immunologicals
In case of these biologicals, irrespective of variation insource, composition and strengths, all the products of the samevaccine/ sera/ immunoglobulin, as approved by licensing authorityare considered as included in this schedule. However, consideringthe source, process, technology and other relevant aspects,different products of the same biologicals should be considereddifferently for purposes such as procurement policy, pricing,etc.
22.1-Diagnostic agents
  Medicine Level of Healthcare  
22.1.1 Tuberculin, Purified Protein derivative P,S,T  
22.2-Sera and immunoglobulins (Liquid/ Lyophilized)
  Medicine Level of Healthcare  
22.2.1 Anti-rabies immunoglobulin P,S,T  
22.2.2 Anti-tetanus immunoglobulin P,S,T  
22.2.3 Anti-D immunoglobulin S, T  
22.2.4 Diphtheria antitoxin P,S,T  
22.2.5 Hepatitis B immunoglobulin S,T  
22.2.6 Human normal immunoglobulin T  
22.2.7 Snake venom antiserum P,S,T  
  a) Soluble/ liquid polyvalent    
  b) Lyophilized polyvalent    
22.3- Vaccines
(a) All the vaccines which are under Universal ImmunizationProgramme of India (UIP) will be deemed included in thisschedule. Presently, the UIP has BCG, DPT, OPV, measles,Hepatitis B, Japanese encephalitis & Pentavalent Vaccines.
(b) The new vaccines, which have been approved by NationalTechnical Advisory Group on Immunization NTAGI)and planned to begiven under UIP, will be deemed to be included as and when listedin UIP. These vaccines are inactivated polio vaccine (IPV),Measles Rubella (MR) and Rota virus vaccine.
(c)In future, the vaccines which are under consideration, ifand when included in UIP, will also be deemed included from thedate of inclusion in UIP. These are pneumococcal and HPVvaccines.
22.3.1-For universal immunisation
  Medicine Level of Healthcare  
22.3.1.1 BCG vaccine P,S,T  
22.3.1.2 DPT + Hib + Hep B vaccine P,S,T  
22.3.1.3 DPT vaccine P,S,T  
22.3.1.4 Hepatitis B vaccine P,S,T  
22.3.1.5 Japanese encephalitis vaccme P,S,T  
22.3.1.6 Measles vaccine P,S,T  
22.3.1.7 Oral poliomyelitis vaccme P,S,T  
22.3.1.8 Tetanus toxoid P,S,T  
22.3.2-For Specific Group of Individuals
  Medicine Level of Healthcare  
22.3.2.1 Rabies vaccine P,S,T  
Section 23- Muscle relaxants and cholinesterase inhibitors
  Medicine Level of Healthcare Dosage form and strength
23.1 Atracurium S,T Injection 10 mg/ml
23.2 Baclofen S,T Tablet 5 mgTablet 10 mgTablet 20 mg
23.3 Neostigmine S,T Tablet 15 mgInjection 0.5 mg/ml
23.4 Succinylcholine S,T Injection 50 mg/ml
23.5 Vecuronium S,T Powder for Injection 4 mgPowder for Injection 10 mg
Section 24- Medicines for neonatal care
  Medicine Level of Healthcare Dosage form and strength
24.1 Alprostadil T Injection 0.5 mg/ml
24.2 Caffeine S,T Oral liquid 20 mg/mlInjection 20 mg/ml
24.3 Surfactant S,T Suspension for intratracheal instillation (As liensed)
Section 25- 0phthalmological Medicines
25.1- Anti-infective medicine
  Medicine Level of Healthcare Dosage form and strength
25.1.1 Acyclovir P,S,T Ointment 3%
25.1.2 Ciprofioxacin P,S,T Drops 0.3%Ointment 0.3%
25.1.3 Erythromycin P,S,T Ointment 0.5%
25.1.4 Gentamicin P,S,T Drops 0.3%
25.1.5 Natamycin P,S,T Drops 5%
25.1.6 Povidone iodine P,S,T Drops 0.6%Drops 5%
25.2-Antiinflammatory medicine
  Medicine Level of Healthcare Dosage form and strength
25.2.1 Prednisolone P,S,T Drops 0.1%Drops 1%
25.3-Local anaesthetics
  Medicine Level of Healthcare Dosage form and strength
25.3.1 Prop arac aine P,S,T Drops 0.5%
25.4-Miotics and anti glaucoma medicines
  Medicine Level of Healthcare Dosage form and strength
25.4.1 Acetazolamide P,S,T Tablet 250 mg
25.4.2 Pilocarpine P,S,T Drops 2%Drops 4%
25.4.3 Timolol P,S,T Drops 0.25%Drops 0.5%
25.5-Mydriatics
  Medicine Level of Healthcare Dosage form and strength
25.5.1 Atropine P,S,T Drops 1%Ointment 1%
25.5.2 Homatropine P,S,T Drops 2%
25.5.3 Phenylephrine P,S,T Drops 5%Drops 10%
25.5.4 Tropicamide P,S,T Drops 1%
25.6-Ophthalmic surgical aids
  Medicine Level of Healthcare Dosage form and strength
25.6.1 Hydroxypropyl methylcellulose T Injection 2%
25.7-Miscellaneous
  Medicine Level of Healthcare Dosage form and strength
25.7.1 Carboxymethylcell ulose P,S,T Drops 0.5%Drops 1%
Section 26-Oxytocics and Antioxytocics
26.1-Oxytocics and abortifacient
  Medicine Level of Healthcare Dosage form and strength
26.1.1 Dinoprostone S,T Tablet 0.5 mgGel 0.5 mg
26.1.2 Methylergometrine P,S,T Tablet 0.125 mgInjection 0.2 mg/ml
26.1.3 Mifepristone T Tablet 200 mg
26.1.4 Misoprostol T Tablet 100 mcgTablet 200 mcg
26.1.5 Oxytocin S,T Injection 5 IU/mlInjection 10 IU/ml
26.2-Medicines used in pre term labour
  Medicine Level of Healthcare Dosage form and strength
26.2.1 Betamethasone P,S,T Injection 4 mg/ml
26.2.2 Nifedipine S,T Tablet 10 mg
Section 27-Psychotherapeutic medicines
27.1-Medicines used in psychotic disorders
  Medicine Level of Healthcare Dosage form and strength
27.1.1 Clozapine T Tablet 25 mgTablet 50 mgTablet 100 mg
27.1.2 Fluphenazine S,T Depot Injection 25 mg/ml
27.1.3 Haloperidol S,T Tablet 5 mgTablet 10 mgTablet 20 mgOral liquid 2 mg/ 5ml
27.1.4 Risperidone P,S,T Tablet 1 mgTablet 2 mgTablet 4 mgOral liquid 1 mg/ml
27.2-Medicines used in mood disorders
27.2.1-Medicines used in depressive disorders
  Medicine Level of Healthcare Dosage form and strength
27.2.1.1 Amitriptyline P,S,T Tablet 10 mgTablet 25 mgTablet 50 mgTablet 75 mgTablet 5 mg
27.2.1.2 Escitalopram S,T Tablet 10 mgTablet 20 mg
27.2.1.3 Fluoxetine P,S,T Capsule 10 mgCapsule 20 mgCapsule 40 mgCapsule 60 mg
27.2.2-Medicines used in Bipolar disorders
  Medicine Level of Healthcare Dosage form and strength
27.2.2.1 Lithium S,T Tablet 300 mg
27.2.2.2 Sodium valproate P,S,T Tablet 200 mgTablet 500 mg
27.3-Medicines used for Generalized Anxiety and SleepDisorders
  Medicine Level of Healthcare Dosage form and strength
27.3.1 Clonazepam P,S,T Tablet 0.25 mgTablet 0.5 mgTablet 1 mg
27.3.2 Zolpidem P,S,T Tablet 5 mgTablet 10 mg
27.4-Medicines used for obsessive compulsive disorders andpanic attacks
  Medicine Level of Healthcare Dosage form and strength
27.4.1 Clomipramine S,T Capsule 10 mgCapsule 25 mgCapsule 75 mg
27.4.2 Fluoxetine P,S,T Capsule 10 mgCapsule 20 mgCapsule 40 mgCapsule 60 mg
Section 28-Medicines acting on the respiratory tract
28.1-Antiasthmatic medicines
  Medicine Level of Healthcare Dosage form and strength
28.1.1 Budesonide P,S,T Inhalation (MDI/DPI) 100 mcg/doseInhalation (MDI/DPI) 200 mcg/doseRespirator solution for use in nebulizer 0.5 mg/mlRespirator solution for use in nebulizer 1 mg/ml
28.1.2 Budesonide (A)+Formoterol (B) P,S,T Inhalation (MDI/DPI) 100 mcg (A) + 6 mcg (B)Inhalation (MDI/DPI) 200 mcg (A) + 6 mcg (B)Inhalation (MDI/DPI) 400 mcg (A) + 6 mcg (B)
28.1.3 Hydrocortisone P,S,T Injection 100 mgInjection 200 mg
28.1.4 Ipratropium P,S,T Inhalation (MDI/DPI) 20 mcg/doseRespirator solution for use in nebulizer 250 mcg/ml
28.1.5 Salbutamol P,S,T Tablet 2 mgTablet 4 mgOral liquid 2 mg/5 ml Inhalation (MDI/DPI) 100 mcg/doseRespirator solution for use in nebulizer 5mg/ml
28.1.6 Tiotropium P,S,T Inhalation (MDI) 9 mcg/doseInhalation (DPI) 18 mcg/doseMDI- Metered dose inhalerDPI- Dry Powder inhaler
Section 29-Solutions correcting water, electrolytedisturbances and acid-base disturbances
  Medicine Level of Healthcare Dosage form and strength
29.1 Glucose P,S,T Injection 5%Injection 10%Injection 25%Injection 50%
  Glucose (A) +    
29.2 Sodium chloride (B) P,S,T Injection 5% (A) + 0.9% (B)
29.3 Oral rehydration salts P,S,T As licensed
29.4 Potassium chloride P,S,T Injection 150 mg/mlOral liquid 500 mg/5 ml
29.5 Ringer lactate P,S,T Injection (as per IP)
29.6 Sodium bicarbonate P,S,T Injection (as per IP)
29.7 Sodium chloride P,S,TS,T Injection 0.9%Injection 0.45%Injection 3%
29.3- Miscellaneous
  Medicine Level of Healthcare Dosage form and strength
29.3.1 Water for Injection P,S,T Injection
Section 30-Vitamins and minerals
  Medicine Level of Healthcare Dosage form and strength
30.1 Ascorbic acid (Vitamin C) P,S,TP,S,T Tablet 100 mgTablet 500 mg
30.2 Calcium carbonate P,S,TP,S,T Tablet 250 mgTablet 500 mg
30.3 Calcium gluconate P,S,T Injection 100 mg/ml
30.4 Cholecalciferol P,S,T Tablet 1000 IU,Tablet 60000 IUOral liquid 400 IU/ml
30.5 Nicotinamide P,S,T Tablet 50 mg
30.6 Pyridoxine P,S,T Tablet 10 mgTablet 50 mgTablet 100 mg
30.7 Riboflavin P,S,T Tablet 5 mg
30.8 Thiamine P,S,T Tablet 100 mgInjection 100 mg/mlCapsule 5000 IUCapsule 50000 IU
30.9 Vitamin A P,S,T Capsule 100000 IUOral liquid 100000 IU/mlInjection 50000 IU/ml
Explanation.
(1)Any dosage form of a medicine, other than the dosage form included in this Schedule, but in same strength and route of administration, which does not have significant difference in terms of pharmacokinetics or pharmacodynamics or efficacy-safety profile over the dosage form mentioned in the list shall be considered as included. To elaborate, if a tablet is included, other dosage forms like conventional tablets and capsules are considered as included. However, such different dosage forms should be considered differently for purposes such as procurement policy, pricing, etc. This principle also applies to all other dosage forms e.g. oral liquid dosage forms, injectables, topical dosage forms, etc.
(2)Innovation in medicine must be encouraged. The formulations developed through incremental innovation or novel drug delivery systems like lipid/liposomal formulations, sustained release/controlled release etc. should be considered as included only if specified in the list against any medicine. Such different formulations should be considered differently for purposes such as procurement policy, pricing, etc.
(3)In cases, where vaccines or immunoglobulins or sera are listed in this Schedule, irrespective of variation in source, composition and strength, all the products of the same vaccines or immunoglobulins or sera as approved by the licensing authority are considered included.
(4)In general, medicines have been mentioned with respect to their active moieties, without mentioning the salts and, in cases where there is significant difference between the salts, the medicine finds mention as its specific salt.
(5)In cases where an active moiety is available as different isomers or analogues or derivatives, they are considered as separate entities, and inclusion of one does not imply inclusion of all isomers or analogues or derivatives.
(6)For injectable preparations, the pack size (single and multi-dose packs) has not been mentioned. It is suggested that the single and multi-dose pack sizes be considered as separate entities for purposes such as procurement/ pricing etc.